MCM5 is a Novel Therapeutic Target for Glioblastoma.
Jian ZhouHousheng ZhengHuiru ZhangWenqiang YuBaoer LiLiang YeLu WangPublished in: OncoTargets and therapy (2024)
This study identifies MCM5 as a key player in GBM, demonstrating its prognostic significance and potential therapeutic relevance by elucidating its role in promoting cell proliferation and resistance to chemotherapy.